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Terminal differentiation of the keratinocytes (cornification) 
has been linked to a restricted supply of retinol. Retinol is 
distributed to target cells by the retinol-binding protein 
(RBP) , which circulates in the plasma in complex with 
transthyretin (TTR). In this study w e have addressed the 
question of retinol delivery to the epidermis via RBP. 
Retinol radiobinding assays , affinity chromatography with 
TTR coupled to Sepharose beads, polyacrylamide gel elec-
trophoresis, and immunoblotting techniques were used to 
show that epidermal extracts contain retinol binding sites 
with no affinity for TTR. Immunoreactive RBP was de-
tected in the epidermal extracts. The RBP in the epidermis 
was in the apoform (without retinol) in contras t to serum 
where the m ajority of RBP is in the holoform (with reti-
I n vitro tissue culture studies have verified that vitamin A is a critica l [lctor in the di ffe rentiation process o f the kerati-nocyte (1) . If the medium is depleted of vitamin A, terminal differentiation is enhanced and the keratinocytcs stratify in a m ann er similar to th at seen in vivo. The high proportion 
of terminally di ffe rentiated cornified cells in the no rmal epidermis 
has therefo re been attributed to a res tricted supply in vitamin A 
(1) . Consequently, w hile retinol is necessary fo r initial growth 
and maturation of the epidermis, its terminal differentiation oc-
curs in the absence o f retinol. Whether and how this switch in 
retinol availability o r delivery occurs in vivo is presently un-
known. 
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Abbreviations: 
BSA: bovine serum albumin 
CRABP: cellular retinoic acid-binding protein 
CRBP: cellular retinol-binding protein 
HPLC: high-perfo rmance liquid chromatography 
PAGE: polyacrylamide gel electrophoresis 
PB S: 5 mM sodium phosphate, 0. 13 M NaCI, pH 7.2 
RBP: (holo- or apo-) : plasma retinol-binding pro tein (with or 
without retinol) 
SDS: sodium dodecyl sul fa te 
TTR: transthyretin 
nol) . Epidermal RBP w as converted in vitro into the hol-
oform only after addition of 20 times more retinol, which 
was needed to reconstitute holoforms of RBP in dermal 
extracts , human buccal mucosal extracts, and delipidized 
normal serum or purified delipidized RBP. Moreover, sev-
eral immunoreactive RBP bands (possibly degradation 
products) w ere identified in the epidermal but not in dermal 
extracts. Retinol-binding pro tein from nonkeratinizing l1U-
man oral mucosa show ed di fferent immunoblotting pat-
terns w hen compared to epidermal RBP. 
These results sugges t that degradation of RBP within 
the epidermis may result in a decreased retinol supply to 
the keratinocytes, and may lead to the cornification of the 
epidermis . J Invest D el'l'l1ato/ 88:403-408, 1987 
Retino l-binding pro tein (RB P) (1) is the specific blood ca rrier 
in transpo rting retinol from li ver to the ta rget tissues [2,3). Ret-
inol-binding pro tein is a low -m olecular-weight (21 kD) protein . 
When bound to retinol it in teracts strongly with transthyretin 
(TTR) previously called prea lbumin [2,3). Cellular up take of ret-
inol has been proposed to be a plas m a m embrane RBP receptor-
m ediated process [4-6). In vitro, human epidermis has been fo und 
to accumulate retinol fro m serum RB P (7) . T he RBP does not 
appear to enter the cell but rather dissociates from the receptor 
and seemingly returns to the circulation (8). Al terations in the 
RBP delivery m ay acco unt for a decreased retino l ava ilability in 
the di ffe rentiated layers of the epiderm is. 
Few studies are available on the presence of RBP in human or 
nonhuman skin sa mples. Immunohistologic studies reported by 
Forsum et al (9) sugges t that tissue-bound RBP is m ainl y located 
extracellularly in the stratum granulosum and corneum and no t 
in the dermis. Studies by Sundelin et al (1 0) revealed that RBP 
m ay occur intracellularl y. Autoradiograph y and immunoflu o res-
cence stud ies by Benoldi et al (1 1) have shown that RBP is con-
fin ed in dermis. Finall y, Torma and Vahlquist (12) have de tected 
immunologicall y reacting compound in the epidermis identical 
to RBP as es tablished by radi al immunodiffusion technique. Im-
munologic m ethods, how ever, cann ot distin guish the holo- (with 
retinol) fro m the apo- (without retinol) form of RBP. T his dis-
tinction is of m aj or impo rtance in understanding retinol delivery 
and RBP m etabo lism . T herefore, we have now used appropriate 
techniques to study both holo- and apofo rms ofRBP in the human 
epidermis and to estimate retinol binding affini ties. 
MATERIA LS AND METH ODS 
T he [11 ,12-3H)all-tra l"ls-retinoic acid (30 C i/ mmol) used was a gift 
fro m F. H offm ann-La Roche (Basel, Switzerland). [15-3H ]All-
trails-retinol (14.3 C i/ mmol) and Bioflu o r were purchased fro m 
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N EN (F. R. G. ). AII-tral1s-retinoic acid , all-tral1s-retin ol, and an-
tiproteases w ere purchased from Sigma (St. Louis, Missouri). 
Purity o f retino ids w as checked by high-perfo rm ance liquid chro-
m atograph y (HPLC) [1 3]. Solutions o f retin oids w ere sto red at 
- 20°C in absolute ethanol containing 0.05 % butylated hydrox-
yto luene. Nitrocellulose sheets were obtained from Bio-Rad 
(Ri chmond , Califo rnia), the densitometer, TLC Scanner 76510 
from Ca mag (Muttenz, Switzerl and), and the Polytron PT7 ho-
mogenizer from Kinem atica (Lucerne, Switzerl and) . Complete 
and in complete Freund 's adju va nts were obtained fro m Di fco 
(Detroit, Michiga n) . Rabbit antigoa t IgG Fab frag ments were 
purchased from Cappel (Cochranville, Pennsylvania). All other 
chemica ls were o f analy tica l g rade. 
Tissue Samples N o rm al human skin samples were obtained 
from hea lthy donors by cosm etic surgery fro m several body sites. 
E pidermis was separa ted from dermis by heat (52°C, 1 min) in 
saline [1 4]. In so me experim ents the epidermis w as obtained by 
using a kerato me set at 0. 18 mm . This procedure res ulted in 
sa mples w ith very littl e dermal contamination as checked by his-
tology. Sa mples were sto red at -70°C. 
N orm al non inflamed human o ral mucosa was obtained from 
surgica l excision during extractions o f wisdom teeth . T he tissue 
was washed several times in salin e and compressed between pieces 
of ga uze in o rder to eliminate blood. Hi stologic assess ment of 
th e samples indicated little contamination by dermi s and absence 
of keratin izati on of the epithelium . Samples w ere sto red at - 70°C 
and processed in a mann er similar to skin tissue. 
Tissue Supernata~ts Lyophili zed aliquo ts o f tiss ue sa mpl es 
representin g about 15 m g of epidermis, 30 m g of dermis, o r 15 
m g of mucosa were ho mogenized at full speed for 30 s, 3 tim es 
in 800 iLl of extraction buffer (50 mM T ris, 25 mM N aCI, 2. 5 mM 
EDTA , pH 7.5) using a tissue hom ogenizer [1 5]. Ti ssue super-
natants were o btained after centrifu ga tion at 100,000 g for 60 min 
at 4°C and were immediately used fo r assa ys o r frozen at - 20°C. 
Protein contents were determined using bovine serum albumin 
(BSA) as standard [1 6]. T o the samples analyzed by poly-
acrylamide gel electrophoresis (PAGE) fo llo wed by immuno-
blotting a mi x ture o f antipro teases (0. 025 mM N-p-tos yl-L-I ysine 
chl oro meth yl ketone, 0.025 mM 1-1-tosylamide 2-phenylethyl 
chlorometh yl ketone, 0.01 mM aprotinin , 0.02 mM leupeptin) w as 
added to the extrac ti on buffer. 
Serum Delipidation N orm al human serum and 2 vol o f meth-
yleth yl ketone were vo rtexed 3 times fo r 4 s (maximum speed) 
at O°C. O rgani c solvent layer was separated by centrifugation fo r 
3 min at 10,000 g and disca rded. T his procedure was repea ted. 
T he sa mple was then flu shed w ith N 2 to evaporate th e solvent 
and the vo lume was readju sted with wa ter to initi al serum vo l-
ume. Identica l p rocedure w as utilized to delipidize pure RBP 
solution . This procedure did no t impair th e binding properties 
of RBP. 
Competitive Radiobinding Assays Vitamin A bindin g pro-
teins were qu antitated by incubating th e sa mples with [11 ,12-
3H] all- tral1s-retin oic acid 50nM o r [15-3H) all-trans-retin ol 50 nM 
[17]. Alcoholi c so lutions o f retin oids containing 0 .5 mg/ml of 
butylated hydroxy toluene were deposited in microtubes and were 
eva porated by a strea m of N 2. Cytosoli c fractions (about 300 iLg 
of pro tein) in a fin al volume ofl 00 iLl were add ed and incubated 
at 4°C fo r 16 h. Fo r binding and competition studi es, an excess 
of 200-fo ld of unl abeled li ga nd w as added in th e sa me manner as 
for radioactive compounds. Samples w ere then subjected either 
to gel fi lt ra ti on on a Sephadex G75 column (0.8 X 15 cm) [1 6] 
o r to charcoa l-dextran technique [15]. 
Affinity Chromatography Affinity chromatograph y on a col-
umn of human TTR co upled to Sepharose 4B was perform ed 
according to Vahlquist et al [1 8). T en millig rams of purified hu-
man T T R [2] was covalen tly coupled with 2 ml o f sw o llen C N Br-
acti va ted Sepharose 4B. T he couplin g effi ciency w as found to be 
97%. A column (0.5 ml) was prepared in a 2-ml syrin ge and 
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equilibrated w ith extraction bu ffer containing 0.1 M N aCI. A 
sm all co lumn with a hi gh ca pacity of binding RBP w as chosen 
to avo id retin o l dissociation in the gel. This column was used 
several times without appreciable loss of binding ca pacity. 
Binding capacity was checked with pure holo-RBP and was 
found to be m ore th an 0.6 m g. Holo-RBP was eluted w ith dis-
tilled w ater adjusted to pH 8 with diluted ammonia solution. 
T ritiated retin ol-binding peaks eluted fro m Sephadex G75 column 
were collected and applied to the TTR-Sepharose column , washed, 
and eluted. Frac tions o f 0.3 ml were collected and th eir radio-
activity assessed in a liquid scintillation counter using 8 ml Bio-
flu o r per fraction. 
Purification ofRBP and Separation of Apo- and Holoforms 
Retin o l-binding protein w as iso lated from human serum as pre-
viously described [2] and purifted by affinity chromatograph y 
[1 8]. The check of purity and the optimal separati on of apo- from 
holo-RBP was carri ed out on verti cal disc PA GE in slab fo rm 
under dim light at 13°C. The runnin g gel contained 7.5% acryl-
amide and 0.2% bisacrylamide using 0.32 M Tri s/CI buffer, pH 
8.9. A prerun of 15 min was ca rried out befo re sa mples were 
appli ed to avo id arti fac ts du e to excess of persul fate. Sample vol-
umes of 5 iLl serum , 100 iLl of epiderm al extracts (- 500 iLg pro-
tein) , dermal extrac ts (400 iLg pro tein) , o r mucosa ex trac ts (400 
iLg pro tein) were applied to each well of the gel. 
Protein Transfer and Immunoblotting Proteins separated 
by PAGE were electro phoreti call y transferred on to a nitrocel-
lulose filter in 0.25 mM sodium phos phate solution and further 
processed acco rdin g to T owbin et al [1 91. To redu ce nonspecific 
binding of the immunoglobulins (l gG), th e filters were incubated 
fo r 1 h in 5 mM sodium phosphate, 0.13 M N aCI, pH 7.2 (PBS) 
containin g 3% BSA (blockin g solution) prio r to a 2-h incubation 
at room temperature in w ashing solution (PBS, 0.5% BSA, 0.2% 
T ween 20) containing suitable amounts o f purified anti-RBP IgG 
or antiserum (see below) . T he filters were then w ashed 3 times 
in w ashin g buffer fo llo wed by incubation of horseradish perox-
idase-labeled rabbit antigoa t IgG Fab fra gments, appropriately 
diluted in w ashin g solution. This incubati on, which las ted 1 h at 
roo m temperature, was terminated by 3 w ashings of the filter in 
washin g so lution . Bound enzyme w as v isualized by incubating 
th e filter in 100 mM Tris/H CI buffer (pH 7.4), containing 0.5 
mg/ ml of diaminobenzidine and 0.03% l-h 0 2' T he percentage of 
apo- to ho lo-RBP was estimated by optical densitometry. 
Goat Monospecific Immunoglobulin Against Human RBP 
A 2-ml solution ofR BP (0.4 m g/ml) in PBS was emulsified with 
an equal vo lume of complete Freund 's adjuvant and inj ected s.c. 
in multipl e spo ts on th e back o f a goat . The procedure was re-
pea ted 3 times at weekl y in tervals with incomplete Freund 's ad-
juvant. 
The serum fro Ql the bleedin g 7 da ys after the las t inj ection was 
used fo r fur ther purification. M onospecific goa t antihuman RBP 
antibodi es were purifi ed by passage of th e immunoa bsorbed im-
munoglobulin anti serum throu gh a colul11n containing highly 
purified human RBP coupled to Sepharose 4B . After extensive 
washin g with PBS, specifi c IgGs were eluted w ith 3 M KSC N 
and th en dialyzed aga inst P BS and concentrated . The specificity 
o f bo th th e m onospecifi c IgGs and immunoabso rbed antiserum 
were verified by radial immunodiffusion and iml11unoblottin g 
techniques with whole serum and pure RBP. 
Metabolism Studies In o rder to ensure th at retin ol o r retinoic 
acid was no t metabolized under our binding assay conditions, 
supern atant tissue fractions were incubated with 1 J-LM of either 
[3H]retino l o r [3H)retin oic acid at 4°C for 18 h. The cytosol was 
th en acidifi ed to pH 4. 0 with diluted H C I before it was ex trac ted 
with 2 X 1 ml dieth yl ether, fo ll ow ed by dryin g. The o rganic 
phase o f th e residue was reconstituted in 50 iLl o f ethano l and 
subj ected to HPLC on a monom eri c C I ~ reversed- phase column 
(TSK, M C H 5, 25 X 4 mm) . A two-solvent system was used: 
solvent A , 100% m eth anol; solvent B , 10 mM ammonium acetate 
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in water. An isocratic elution with a mixture of 80% solvent A 
and 20% solvent B for 12 min at 1 mllmin was fo llowed by a 
linear gradient to 94% of solvent A for 12 min. Fractions of 0.5 
ml were collected, and their radioactivity assessed in a liquid 
scintillation counter using 5 ml Biofluor per fraction. 
Retinol-RBP Dissociation Studies The possible dissociation 
of retinol from its RBP during protein extraction procedure was 
considered . First, serum was homogenized in conditions similar 
to those utilized for tissues. Second, serum diluted 1/10 or 1/50 
in 800 ,ul of extraction buffer was incubated with the pellet re-
sulting from proteins extracted from dermis, epidermis, or whole 
skin. Third, serum diluted at 1/10 or 1/50 with an epidermal 
protein extract was incubated in the same conditions as for ra-
diobinding assays. In all the cases cited above, supernatants were 
analyzed by immunoblotting technique. 
RESULTS 
Epidermal Extracts Contain Retinol-Binding Sites With No 
Affinity to TTR Table I shows the [3H]retinoid-binding ac-
tivities of epidermal extracts measured by the charcoal-dextran 
technique. In all cases [3H]retinoic acid-binding was very specific 
and could not be displaced significantly by an excess of retinol , 
never exceeding 15% of the total binding. These binding activities 
are due to the presence of cellular retinoic acid-binding protein 
(CRABP) [20]. About 50% of[3H]retinol-binding activity could 
be displaced in some samples by retinoic acid. This result suggests 
the presence of RBP which can bind in vitro both retinol and 
retinoic acid with the same aff1l1ity [20]. Qualitative analysis was 
then performed to identify the RBP. 
Figure 1 shows the elution profile of an epidermal extract in-
cubated with [3H]retinol. Two radioactive peaks corresponding 
to retinol-binding activity were detected. The first peak, excluded 
from the gel, had a high molecular weight. The second peak was 
not distinguishable from the purified RBP used to standardize the 
column. Moreover, in some samples, addition of an excess of 
retinoic acid partially displaced the binding of the 2 radioactive 
peaks. When these 2 peaks were separately subjected to the TTR 
affinity column chromatography almost all radioactive retinol 
was found eluted, indicating no affinity for human TTR. Dis-
sociation buffer released only trace amounts of radioactivity. 
Figure 2 shows a representative elution profile obtained when 
the high-molecular-weight radioactive peak was analyzed by this 
affinity column. An identical elution profile was obtained with 
the second radioactive peak. 
Polyacrylamide Gel Electrophoresis and Immunoblotting 
Techniques Detect Different RBP Species in Serum, Epi-
dermis, and Dermis 
Electrophoret ic Mobility oJPurified RBP: Purified RBP from serum 
were analyzed by PAGE and sodium dodecyl sulfate (SDS)-PAGE 
as shown in Fig 3. Freshly prepared RBP exhibits a lower elec-
trophoretic mobility for holo-RBP than for apo-RBP. Excessive 
handling of RBP gives rise to some denaturation products as 
evidenced by the following pattern: native holo- and apoform, 
Table I. Cellular Retinoic Acid-Binding Protein (CRABP) 
and Cellular Retinol-Binding Protein (CRBP) Binding 
Activities and Specificities in Normal Human Epidermis 
CRABP" + 
Milligrams CRABP CHBP Retinol 
No. of Protein per 
Samples Gram Tissue (pmollmg protein) 
10 65 ± 2.4 ± 0.95 ± 
7.1h 0.24 0.18 
Charcoal-dextran technique; details given in text. 
' Specificity analysis with excess of retinoids. 
bStandard error of the mean. 
'Range. 
0.35 ± 
0.03 
CHBP" + 
Retinoic 
Acid 
0.36 
(0-0.5), 
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Figure 1. Gel filtration analysis on Sephadex G75 column of human 
epidermis. Supernatant (0.3 mg protein) was incubated with 50 nM [3H) 
retinol (open circles), in the presence of an excess of 200-fold retinoic acid 
(solid circles) or in the presence of an excess of 200-fold retinol (solid 
triangles) . 
and denatured holo- and apoform [21] . Delipidation of RBP so-
lution resulted in 2 bands: native apo- and denatured apo-RBP. 
The method of deli pi dation used here is more efficient, retinol is 
extracted at 100%, and faster (about 30 min) than those described 
previously [21,22J . Despite the charge of heterogeneity ofRBP, 
the protein is homogeneous with regard to the size when analyzed 
in 5-20% slab SDS-P AGE. These results are in accordance with 
those of other studies [23,24] . 
R etinol-Binding Protein Species in Normal Human Serum: Poly-
acrylamide gel electrophoresis followed by immunoblotting tech-
nique was used to study sera samples. Normal human sera showed 
a major band (about 95%) ofholo- and a slight band (about 5%) 
of apo-RBP (Fig 4). No heterogeneity of RBP in fresh or frozen 
sera could be detected in more than 20 normal sera analyzed. 
1200 -r---------. 
BOO 
400 ~ 
B 
J 
10 20 
Fraction number (0.2 mil 
Figure 2. Human TTR coupled to Sepharose affinity chromatography. 
Tritiated retinol activities after Sephadex G75 were deposited on the col-
umn and washed with extraction buffer (A). Elution was performed with 
dissociation solution (B). 
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Figure 3. Po lyacry lamide gel electro pho res is o f n o rmal human se rum 
and purified HBP . Slab g el PA GE (7.5%) with 5 p.lno rmal hUlll an se rulll 
(Ialle I), 20 p.g of fres hl y purifi ed hum an RBP (lall e 2), 8 p.g of excess ive 
handlin g of purified RBP (la ll e 3), and 8 p.g of d elipi zed pure HBP (lalle 
4). Pure I"l.BP , JO p.g o n SDS-PA GE 5-20% slab ge l (la lle 5). 
Delipidatio n of serum readily dissociated retinol from the ho lo-
RBP, giv in g o ne sharp band o f apo-RBP. Total reconstitution 
was obtained after addit io n of 10 J.LM retinol. This va lue is about 
50 times hi g her th<Jn th e Kd o f retinol for pure RBP /25]. 
E lect ro phoresis dissociates the co mplex RBP-TTR frol11 the 
blood totally , so that immunoreactive bands showed free RBP 
forms. T hi s was confirmed by the sa me electrophoretic mobi lity 
o bserved for RBP in th e serum and for pure RBP. 
Retil1ol-Billdillg Proleill Species ill Derll/al, Ep idemwl, and I\lllIcosal 
Exlracts: Dermal and epidcrmal extra cts wcrc subjected to the 
PAGE-immunoblo ttin g techniqu e undcr the sa l11e conditions as 
for scrum (Fig 5). Dcrmal extracts showed on ly a major band of 
apo-RBP but w hcn incubated with 10 J.LM retinol they showed 
tota l reconst itution. 
Epidermal ex tracts (frol11 both hcat-separated and keratomized 
sa mpl es) showed very differcnt immunoblotti ng patterns (Fig 5). 
holo 
apo 
2 3 4 5 6 7 
Figure 4. Illllllun o bl orr in g of n o rmal human se rum (NH S) usin g goa t 
antihulll an HBP serum. Sa mples (5 p.1 ) were subj ected to PAGE and 
c1ectropho retica ll y transferred to a nitrocellulose filter. L llll es 1 ll lIri 2, NHS 
and delipidi zed NH S; Iml es 3-6, dclipidi zed NH S in cubated w ith 1, 2.5, 
5, and 10 P.M ret ino l, respectively ; lalle 7, 0.4 p.g of purified RBP. An-
tibodies bo und to th e fi lter were detected w ith perox idase-conjugated 
IgG, and vis uali zed w ith diamin o bcn zid ine co lo ri za tion , as described in 
Materials mId Methods. 
holo 
apo 
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Figure 5. Immul1o b lottil1 g of RBI' species in ep ide rmis, dermis, and 
mucosa. Tissue ext racts were su bjected to PAGE and e lectrophoretica ll y 
tran sferred to nitroce llul ose. Dermal extracts (250 p.g protein / lane) were 
incubated without (lallc 1) o r with 10 P.M re tino l (lilli e 2). Epiderma l 
ex tracts (300 p.g protein / lane) were incubated w ithout (lall e 3) , with 10 
P.M (lilli e 4) and with 200 P.M retino l (lall c 5). Mucosa ext ra cts (250 p.g/ lane) 
were in cubated w itho ut (latH' 6) o r w ith 10 P.M retinol (lalle 7). 
Six distin ct immunoreactive bands w ith slow or fa st electropho-
reti c mobilities wcre detectab le. Protcol yti c activity during ho-
mogeni za tion was minimi zed as antiproteases wcre prcsent in the 
extraction mcdium. O nc of th ese bands correspond ed to apo-
RBI'. In ordc r to estim atc the affinity of retinol for apo-RBP, 
different concentrations of retino l w ere incubated with epidermal 
cxtracts. A bout 80% reconstitution w as obta ined with 200 J.LM , 
i.e., 20 tim cs more retinol than needed for serum. 
O n the other hand, ora l mucosal extracts showed a pattern of 
RBP species diffcrent from those present in the cpidermis and 
dermis (Fig 5) . No signifi cant fa st-, but vario us slow-migrating 
immuno reactive bands were detected. In contrast to that in epi-
dermis, apo-RBP cou ld be partially reconstitutcd into holo-RBP 
w hen Illucosa l cx trac ts wcrc in cubated w ith 10 J.LM retinol. (Table 
II shows the es tim ation of RBP species and ho lo-RBP reconsti-
tution in th esc tissucs.) 
Relillol RBP Dissociation CO I·tlrol Experim ents: To determine pos-
sible dissociation of retinol frolll RBP durin g extraction of tissue 
proteins, w e performed 3 control experimcnts: (a) Minimal retinol 
rel ease fro m RBP was observcd by the PAGE-immunoblotting 
techniquc, w hen serum was subj ccted to thc procedure similar to 
tissue homogcni zation. (b) In cubation of no rmal diluted serum 
with the pellet l'Cs ultin g from protein extraction of dermis and 
epidermis produced a negli gible amount of apo-RBP. These re-
sults show that retinol ca n be onl y partially dissociated from its 
RBP by dcrmal or epidermal components. (c) In cubation of nor-
mal hum an serum w ith cp iderma l supernatants did not result in 
the appearan ce of i Illmunorcactivc RBP bands as co III pared to the 
Table II. Estimation of Retinol-Binding Protein (RBP) 
Species and Holo-RBP Reconstitution 
Se rum 
Dermis 
Ep ide rmis 
Mucosa 
RBP" 
H o lo-RBP % 
% 1-1 010- % Apo- Heconstitution
" 
95 5 
100 
100 
100 
100 
100 
40 
"Es tilll ated rrom IOw l Rill' (3 1'0- + holo ror l1l s). 
bEstil11atcd from in cubati o n with 10 }.LM retino l. 
RBP D egraded 
Forms 
+ 
+ 
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Figure 6. Metabo lism of 13H Iretino l in vitro. E piderm al supernatant 
(opell circles), o r ex tract io n buffer (so lid rircles) were in cubated w ith 13H 1 
retinol ext racted with diethy lethcr. The ex tracted radioactivity was chro-
matographed on reversed-phase HPLC. Details in tcx t. The experiment 
was repea ted 3 timcs. eH)I~ = retino l, e H)RA = retin oic acid . 
imm un oblotting pattern of both serum and epidermal superna-
tants (not shown) . 
MetabolislII S tlldies: Figure 6 illustrates the absence of [3HJretino l 
metabolism in epidermal supernatants and especiall y the absence 
of[3HJretino ic acid formation in vitro. The chro m atographi c pro-
fLies obtained were identica l to th ose for IJHlretino l incubated 
with buffer alo ne. 
DISC USSION 
In order to address retinol delivery to the epidermis via RBP, we 
have stud ied retinol-bindin g capa cities w ith different techniqu es 
in epiderm al extra cts. 
The Retinol Binding Sites of Human Epidermis At least 3 
different retinoid-bindin g proteins arc detected in a tiss ue and 
especially in skin extracts when using radiobinding assay. Two 
of them arc intracellular: cellular retin o l-binding protein (CRBP) 
and cellul ar retinoi c acid-binding protein (CRABP) which spe-
cifica ll y bind retin ol and retinoic aci d , respecti vely (reviewed in 
[26]). T he third is the RBP which, in vitro, binds bo th ret ino ic 
acid or retin ol w ith th e sa me affinity and could therefore interfere 
wi th the radio binding assay [20,27J. Gel filtrati o n o r sucrose gra-
dient techniques used for RBP anal ys is ca nn ot readily disting uish 
free RBP from CRBP beca use of their similar mo lecular weig hts. 
Some of the r3HJretinoi binding activities that we ha ve o bserved 
by radiobindin g assays cannot be entirel y attributed to C RBP, 
since binding of ret ino l was partiall y displaced in some samples 
by retinoi c acid. This m ay suggest th e presence of either C RPB 
(F) (an oncofeta l RBP) w hi ch binds both ret ino l and retinoi c acid 
[28) or RBP. The RBP is almost tota ll y co mplexed to TTR in 
the serum but this probabl y docs not happen in tissues. The 
com plex fo rmation depends on th e concentratio n ofTTR relative 
to that of ho lo- RBP. Transthyretin has been demonstrated to be 
present in very lo w am ounts in rat tiss ue o th er than serum , th y-
roid glands, lungs, li ver, kidney, and heart 129). We d id not detect 
any binding ca pacity fo r RBP in the epidermis by affinity chro-
matography with TTR coupled to Sepharose. 
This result docs not necessa rily preclude that RBP is not present 
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in epidermis since the TTR affinity binding techniqu e ca nnot 
discern qua litative differences in RBP species . For in stance, a 
mod ifi ed epiderm al RBP that possesses no affinity for TTR cou ld 
sti ll bind to retinol. 
The RBP Species of Human Epidermis The concept that 
RBP is respo nsible for the delivery of retino l from li ver to the 
extrahepa ti c ac tio n sites of vitamin A is generaLl y accepted (sec 
review [8]). Alth o ugh no stro ng evidence has been reported that 
RBP leaves the blood and diffuses througho ut dermis to bring 
retino l to epidermi s, the detection of RB P in dermis and epidermis 
m akes this concept acceptable, even if the synthesis of mRNA 
for RB P in tissues other than li ver has been reported [30]. 
Qualitative analys is of RBP species ill tiss ues, including sera, 
is of g reat impo rtance for two reasons. Fi rst, these studies are 
necessary fo r und erstandin g the metabo lism of RBP in no rm al 
and patho logic tissues. Second , such info rmatio n coul d be re lated 
to the putat ive ep iderm al RBP m e111brane receptors in order to 
better understand the mechani sms involved in retino l delivery 
and regul ati on IA,7,8]. To address these questions, we used an 
im111uno blo ttin g technique, which is the most sensiti ve meth od 
for detection of such immuno reactive compounds at present. 
Mo reove r this technique all ows for the identification of a binding 
protein w ith (holo) or w ithout (a po) its li ga nd. T his is the first 
time that such RBP molecules ca n be visualized and their bindin g 
properties studi ed w hen expressed in very low amounts as fo und 
in ti ss ues. 
This technique directl y showed th at normal human se rum con-
tains the 2 forms apo- (5%) and ho lo-RBP (95%). T his is in 
agreement w ith current know ledge indirectly derived from mea-
surement of either vitamin A and tota l RBP [31,32) or ho lo-RB P 
in disc gel rod and tota l RBP 1331. 
O ur results clearl y dem onstrate the presence of RBP , mainl y 
as apo-RBP, in dermis, epidermi s, and o ral mu cosa. Q uali tatively 
RBP and its immuno reactive meta bo li c products are expressed 
very differentl y in these tissues: Surpri singly, dermal extracts 
showed onl y :lpo-RBP, when o ne could expect to find also the 
ho lofo rm because the dermis contains an important microvas-
culari zation and it co uld serve as a transit tissue towa rd the epi-
dermis. E piderm al and oral mu cosa extracts showed, besides 
:lpo-REP, severa l immunoreactive bands pro babl y due to partia l 
hydro lys is of RBP. These bands remained un chan ged w hen 
extraction buffer contain ed a cocktai l of antiproteases excl udin g 
a possible degradati on during protein extract ion . 
Sharp d ifferences were seen w hen comparin g the electro pho-
retic patterns of epiderm al and o ral mu cosa extracts: hi g h mobility 
bands were absent in o ral mu cosa. T hese results suggest th at 
degrad ation of RB P is very low ifnot absent in the dermis w hereas 
it is hig h, altho ugh different , in th e epidermis and ora l mu cosa. 
The fact that no ho lo-RBP was found in these tissues and espe-
ciall y in the dennis could be explained by retino l dissociatio n 
durin g tissue ho mogeni zation, but reassociation would have taken 
place after protein ex tractio n. Inactiva ti on of endogeno us retinol, 
by esterifi ca tio n for example, req uires further studies. 
Most im portantly, apo-RBP from no rm al human serum and 
dermis could be almost tota ll y reconstituted into the ho lofo rm 
with retin ol, w hereas th is did not happen with the apo-RBP from 
the epidermis. It is likely that RBP docs no t diffuse througho ut 
the ep idermis in its intact ho lofo rm , but is rather m etabo li ca ll y 
inact ivated (loss of affinity) and partiall y hyd ro lyzed. The absence 
of intac t ho lo-RBP in ep idermis might be ex plained by the in-
acti vat ion of the binding protein in the · lower layers of the epi-
dermis. Since o ur stud y was nond ynamic in design we cann o t 
exclude the possibility that a certJ in amo unt of RBP m ay leave 
the ep idermis as unm odifi ed apo-RBP; we think that this is un-
likel y considerin g the immunoblotting patterns of the dermis. 
In o ral mu cosa, apo-RBP appea rs to ha ve onl y partiall y lost 
its affi nity so that retino l mig ht still be suppli ed to the upper 
layers of th e epithelium . This sugges ti on is strengthened by the 
fact th at the metabolism of RBP in o r::t1 mu cosa is different fr0111 
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the epidermis as seen in the pattern s obtained by immunoblottin g 
technique. 
From studies on intes tinal mucosa l epi thelial cells fro m the 
monkey 14], pig ment epithelial ce ll s of bovine retin a [34], and rat 
tes tis [35]. it has been suggested th at on ly hol o-RBP could intera ct 
with the cell membrane recepto r for RBP. As far as the epidermis 
is concerned , our results suggest that th is mi ght occur in the 
lowest layers of the epithelium (basal cells?), where RBP might 
give up retinol and itself beco mes structurall y and chemi call y 
modified, with subsequent loss of its affinity for retinol; thus it 
ca nn o t interact an y longer with its receptor. If smaller retinol 
ava ilabilit y is in vo lved in the termin al differentiation of the epi-
dermis, it mi ght be rel ated to the lack of a fun ctionally active 
form of RBP diffusing throughout the epidermi s. 
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